Literature DB >> 33122205

Longitudinal Assessment of Neuroradiologic Features in Wolfram Syndrome.

A Samara1, H M Lugar1, T Hershey2,3,4, J S Shimony4.   

Abstract

BACKGROUND AND
PURPOSE: Wolfram syndrome is a rare genetic disease with characteristic brain involvement. We reviewed the brain MR images of patients with Wolfram syndrome to determine the frequency and characteristics of common neuroradiologic findings.
MATERIALS AND METHODS: We retrospectively reviewed the imaging data of patients with genetically-confirmed Wolfram syndrome who had been recruited to the Washington University Wolfram Syndrome Research Clinic. These patients were evaluated between 2010 and 2019 with annual MRIs, along with other measures. MR images were assessed for clinical neuroradiologic signs at each individual's first and last follow-up visits to characterize the frequency, rate of progression, and clinical correlations of these signs.
RESULTS: We included 30 patients (13 males/17 females; average age at first visit, 14 years; average age at last visit, 19 years). The median duration of follow-up was 5 years (range, 2-9 years). The most common findings were an absent or diminished posterior pituitary bright spot (first, 53%; last, 70%), T1/T2 pons signal abnormalities (first, 53%; last, 67%), optic nerve atrophy (first, 30%; last, 80%), white matter T2 hyperintensities (first, 27%; last, 35%), and cerebellar atrophy (first, 23%; last, 70%).
CONCLUSIONS: Patients with Wolfram syndrome present characteristic neuroradiologic findings that involve the posterior pituitary gland, optic nerves, white matter, brain stem, and cerebellum. These abnormal findings appear at an early age and tend to increase in frequency with time. However, the neurologic significance and neuropathologic mechanisms of each sign require more investigation. Neuroradiologists should be aware of the pattern of these features in Wolfram syndrome.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 33122205      PMCID: PMC7963228          DOI: 10.3174/ajnr.A6831

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype.

Authors:  Francesca M Elli; Stefano Ghirardello; Claudia Giavoli; Silvana Gangi; Laura Dioni; Milena Crippa; Palma Finelli; Silvia Bergamaschi; Fabio Mosca; Anna Spada; Paolo Beck-Peccoz
Journal:  Gene       Date:  2012-07-04       Impact factor: 3.688

2.  Evidence of retinal degeneration in Wolfram syndrome.

Authors:  Matteo Scaramuzzi; Priyanka Kumar; Neal Peachey; Paolo Nucci; Elias I Traboulsi
Journal:  Ophthalmic Genet       Date:  2018-12-03       Impact factor: 1.803

3.  Hyperintense signal of the posterior pituitary on T1-weighted MR images: an experimental study.

Authors:  I Fujisawa; R Asato; M Kawata; Y Sano; K Nakao; T Yamada; H Imura; Y Naito; K Hoshino; S Noma
Journal:  J Comput Assist Tomogr       Date:  1989 May-Jun       Impact factor: 1.826

4.  Posterior lobe of the pituitary in diabetes insipidus: MR findings.

Authors:  I Fujisawa; K Nishimura; R Asato; K Togashi; K Itoh; S Noma; Y Kawamura; T Sago; S Minami; Y Nakano
Journal:  J Comput Assist Tomogr       Date:  1987 Mar-Apr       Impact factor: 1.826

5.  MRI of Wolfram syndrome (DIDMOAD).

Authors:  P Galluzzi; G Filosomi; I M Vallone; A M Bardelli; C Venturi
Journal:  Neuroradiology       Date:  1999-10       Impact factor: 2.804

6.  Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome.

Authors:  E Pakdemirli; N Karabulut; L S Bir; Y Sermez
Journal:  Australas Radiol       Date:  2005-04

7.  Wolfram syndrome presenting marked brain MR imaging abnormalities with few neurologic abnormalities.

Authors:  S Ito; R Sakakibara; T Hattori
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

Review 8.  Wolfram syndrome: MAMs' connection?

Authors:  Benjamin Delprat; Tangui Maurice; Cécile Delettre
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

9.  Early brain vulnerability in Wolfram syndrome.

Authors:  Tamara Hershey; Heather M Lugar; Joshua S Shimony; Jerrel Rutlin; Jonathan M Koller; Dana C Perantie; Alex R Paciorkowski; Sarah A Eisenstein; M Alan Permutt
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

Review 10.  Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses.

Authors:  Amjad Samara; Rachel Rahn; Olga Neyman; Ki Yun Park; Ahmad Samara; Bess Marshall; Joseph Dougherty; Tamara Hershey
Journal:  Orphanet J Rare Dis       Date:  2019-12-03       Impact factor: 4.123

View more
  3 in total

1.  Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model.

Authors:  Kadri Seppa; Toomas Jagomäe; Kaia Grete Kukker; Riin Reimets; Marko Pastak; Eero Vasar; Anton Terasmaa; Mario Plaas
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

2.  Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype.

Authors:  Toomas Jagomäe; Kadri Seppa; Riin Reimets; Marko Pastak; Mihkel Plaas; Miriam A Hickey; Kaia Grete Kukker; Lieve Moons; Lies De Groef; Eero Vasar; Allen Kaasik; Anton Terasmaa; Mario Plaas
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

3.  Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome.

Authors:  Sarah A Eisenstein; Raveena S Boodram; Courtney L Sutphen; Heather M Lugar; Brian A Gordon; Bess A Marshall; Fumihiko Urano; Anne M Fagan; Tamara Hershey
Journal:  Front Neurosci       Date:  2022-04-12       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.